Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Clinical trial NCT06031688 · RECRUITING

Trial details

NCT number: NCT06031688
Sponsor: SWOG Cancer Research Network
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Lung Non-Small Cell Carcinoma Stage IV Lung Cancer AJCC v8

Start date: 2024-08-08
Primary completion: 2028-05-31
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.